Vaughan David Investments LLC IL Buys Shares of 1,320 The Clorox Company (NYSE:CLX)

Vaughan David Investments LLC IL bought a new position in The Clorox Company (NYSE:CLXFree Report) in the first quarter, according to its most recent disclosure with the SEC. The firm bought 1,320 shares of the company’s stock, valued at approximately $202,000.

Other institutional investors have also modified their holdings of the company. Fortitude Family Office LLC purchased a new stake in shares of Clorox in the fourth quarter valued at about $29,000. Venturi Wealth Management LLC boosted its holdings in Clorox by 308.5% in the 1st quarter. Venturi Wealth Management LLC now owns 192 shares of the company’s stock valued at $29,000 after purchasing an additional 145 shares during the last quarter. Northwest Financial Advisors purchased a new stake in shares of Clorox in the 4th quarter valued at approximately $29,000. Core Wealth Advisors Inc. acquired a new stake in shares of Clorox during the 4th quarter worth approximately $29,000. Finally, First United Bank & Trust purchased a new stake in shares of Clorox during the 4th quarter valued at approximately $31,000. Hedge funds and other institutional investors own 78.53% of the company’s stock.

Analyst Ratings Changes

Several research analysts recently weighed in on the company. Deutsche Bank Aktiengesellschaft lowered their price objective on Clorox from $155.00 to $151.00 and set a “hold” rating for the company in a research report on Wednesday, April 17th. DA Davidson reissued a “neutral” rating and set a $162.00 price objective on shares of Clorox in a research report on Wednesday, April 17th. Morgan Stanley reaffirmed an “equal weight” rating and issued a $160.00 target price on shares of Clorox in a research report on Tuesday, March 26th. UBS Group lowered their target price on shares of Clorox from $164.00 to $159.00 and set a “neutral” rating for the company in a research note on Wednesday, May 1st. Finally, Jefferies Financial Group raised shares of Clorox from an “underperform” rating to a “hold” rating and set a $145.00 price target on the stock in a research note on Tuesday, March 26th. Six research analysts have rated the stock with a sell rating and fourteen have issued a hold rating to the company’s stock. According to MarketBeat.com, Clorox has an average rating of “Hold” and a consensus price target of $142.13.

Get Our Latest Research Report on Clorox

Clorox Stock Up 0.2 %

NYSE:CLX traded up $0.25 during midday trading on Wednesday, reaching $132.81. The company had a trading volume of 767,553 shares, compared to its average volume of 1,232,009. The Clorox Company has a 12-month low of $114.68 and a 12-month high of $169.14. The firm has a market capitalization of $16.49 billion, a price-to-earnings ratio of 68.81, a PEG ratio of 1.97 and a beta of 0.39. The company has a current ratio of 0.90, a quick ratio of 0.53 and a debt-to-equity ratio of 9.73. The stock’s fifty day simple moving average is $133.80 and its 200-day simple moving average is $142.77.

Clorox (NYSE:CLXGet Free Report) last announced its quarterly earnings data on Tuesday, April 30th. The company reported $1.71 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.33 by $0.38. Clorox had a return on equity of 302.49% and a net margin of 3.33%. The business had revenue of $1.81 billion during the quarter, compared to analysts’ expectations of $1.87 billion. During the same quarter last year, the business posted $1.51 EPS. The business’s quarterly revenue was down 5.3% compared to the same quarter last year. On average, sell-side analysts anticipate that The Clorox Company will post 5.92 earnings per share for the current fiscal year.

About Clorox

(Free Report)

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.

Read More

Institutional Ownership by Quarter for Clorox (NYSE:CLX)

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.